Podcast•Mar 2, 2026•0 min
#382 ‒ AMA #80: Longevity Optimization Through Strength Benchmarks, VO₂ Max Targets, Nutrition Principles, Brain Health, Supplements, GLP-1 RAs, Wearables,...
In this AMA episode, host Peter Atiyah answers listener questions on practical longevity strategies, covering strength metrics (relative strength, grip, lower‑body power), starter exercise routines for time‑pressed beginners, and the role of complex movement for brain health. He emphasizes normalized strength benchmarks (push‑ups, goblet squats, sit‑to‑stand) and power assessments like broad jumps, while recommending a habit‑first approach: daily walking plus twice‑weekly resistance work. The discussion also touches on insulin resistance detection, evidence‑based supplements, GLP‑1 receptor agonists, wearable data use, sleep optimization, VO₂ max targets, and simple nutrition principles, highlighting sleep, exercise, and emotional health as the top levers for extending healthspan.
By The Peter Attia Drive / Articles
News•Feb 28, 2026
Does Lowering Cholesterol Harm the Brain?
The brain houses about 20‑25% of the body’s cholesterol, yet it relies on local synthesis because circulating cholesterol cannot cross the blood‑brain barrier. Although some patients report transient brain fog on statins, large observational studies generally show neutral or even...
By The Peter Attia Drive / Articles
News•Feb 21, 2026
GLP-1 Drugs Fail to Slow Cognitive Decline in Alzheimer’s Disease
Recent randomized trials testing GLP‑1 receptor agonists such as semaglutide and liraglutide in Alzheimer’s disease patients found no measurable slowing of cognitive decline. Earlier post‑hoc and observational analyses had suggested roughly a 50 % reduction in dementia incidence, raising hopes of...
By The Peter Attia Drive / Articles